Found: 28
Select item for more details and to access through your institution.
Cover Image, Volume 23, Issue 10.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 10, p. 1, doi. 10.1111/dom.14542
- Publication type:
- Article
Using machine learning to predict severe hypoglycaemia in hospital.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 10, p. 2311, doi. 10.1111/dom.14472
- By:
- Publication type:
- Article
Impact of SGLT2 inhibitors in comparison with DPP4 inhibitors on ascites and death in veterans with cirrhosis on metformin.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 10, p. 2402, doi. 10.1111/dom.14488
- By:
- Publication type:
- Article
Response to the letter from Horowitz et al. to the Editor relating to the publication 'Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetes' by Dahl et al.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 10, p. 2414, doi. 10.1111/dom.14485
- By:
- Publication type:
- Article
Efficacy of lifestyle intervention in adults with impaired glucose tolerance with and without impaired fasting plasma glucose: A post hoc analysis of Da Qing Diabetes Prevention Outcome Study.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 10, p. 2385, doi. 10.1111/dom.14481
- By:
- Publication type:
- Article
Comparative effectiveness and safety of sodium‐glucose cotransporter‐2 inhibitors versus metformin in patients with type 2 diabetes: An observational study using data from routine care.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 10, p. 2320, doi. 10.1111/dom.14474
- By:
- Publication type:
- Article
Metabolic improvement with short‐term, glucagon‐like peptide‐1 receptor agonist treatment does not improve cardiac diastolic dysfunction in patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 10, p. 2374, doi. 10.1111/dom.14480
- By:
- Publication type:
- Article
Impact of pregnancy on the trajectories of cardiovascular risk factors in women with and without gestational diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 10, p. 2364, doi. 10.1111/dom.14479
- By:
- Publication type:
- Article
A large remaining potential in lipid‐lowering drug treatment in the type 2 diabetes population: A Danish nationwide cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 10, p. 2354, doi. 10.1111/dom.14478
- By:
- Publication type:
- Article
Macronutrient intake, appetite, food preferences and exocrine pancreas function after treatment with short‐ and long‐acting glucagon‐like peptide‐1 receptor agonists in type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 10, p. 2344, doi. 10.1111/dom.14477
- By:
- Publication type:
- Article
What are the factors associated with long‐term glycaemic control in patients with type 2 diabetes and elevated glycated haemoglobin (≥7.0%) at initiation of second‐line therapy? Results from the DISCOVER study.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 10, p. 2336, doi. 10.1111/dom.14476
- By:
- Publication type:
- Article
Dasiglucagon, a next‐generation glucagon analogue, for treatment of severe hypoglycaemia via an autoinjector device: Results of a phase 3, randomized, double‐blind trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 10, p. 2329, doi. 10.1111/dom.14475
- By:
- Publication type:
- Article
Blood glucose monitoring by insulin‐treated pilots of commercial and private aircraft: An analysis of out‐of‐range values.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 10, p. 2303, doi. 10.1111/dom.14471
- By:
- Publication type:
- Article
Response to Dahl et al.: Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 10, p. 2411, doi. 10.1111/dom.14473
- By:
- Publication type:
- Article
Sodium‐glucose cotransporter‐2 inhibitors for type 2 diabetes mellitus in adults: An overview of 46 systematic reviews.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 10, p. 2289, doi. 10.1111/dom.14470
- By:
- Publication type:
- Article
Predictors of diabetes‐related distress before and after FreeStyle Libre‐1 use: Lessons from the Association of British Clinical Diabetologists nationwide study.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 10, p. 2261, doi. 10.1111/dom.14467
- By:
- Publication type:
- Article
Efficacy and safety of dulaglutide 3.0 and 4.5 mg in patients aged younger than 65 and 65 years or older: Post hoc analysis of the AWARD‐11 trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 10, p. 2279, doi. 10.1111/dom.14469
- By:
- Publication type:
- Article
Use of once‐weekly semaglutide in patients with type 2 diabetes in routine clinical practice: Results from the SURE Canada multicentre, prospective, observational study.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 10, p. 2269, doi. 10.1111/dom.14468
- By:
- Publication type:
- Article
Factors associated with switching from sulphonylureas to dipeptidyl peptidase 4 inhibitors among patients with type 2 diabetes in the United States.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 10, p. 2251, doi. 10.1111/dom.14466
- By:
- Publication type:
- Article
Effect of dulaglutide 3.0 and 4.5 mg on weight in patients with type 2 diabetes: Exploratory analyses of AWARD‐11.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 10, p. 2242, doi. 10.1111/dom.14465
- By:
- Publication type:
- Article
Comparable efficacy and safety between LY2963016 insulin glargine and insulin glargine (Lantus®) in Chinese patients with type 1 diabetes: A phase III, randomized, controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 10, p. 2226, doi. 10.1111/dom.14463
- By:
- Publication type:
- Article
Efficacy of liraglutide added to sodium‐glucose cotransporter‐2 inhibitors in type 2 diabetes, stratified by baseline characteristics: Post‐hoc analysis of LIRA‐ADD2SGLT2i.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 10, p. 2234, doi. 10.1111/dom.14464
- By:
- Publication type:
- Article
Weight‐reducing, lipid‐lowering and antidiabetic activities of a novel arginine vasopressin analogue acting at the V1a and V1b receptors in high‐fat‐fed mice.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 10, p. 2215, doi. 10.1111/dom.14462
- By:
- Publication type:
- Article
Ultra‐rapid‐acting insulins for adults with diabetes: A systematic review and meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 10, p. 2395, doi. 10.1111/dom.14461
- By:
- Publication type:
- Article
Lower risk of hospitalization for heart failure, kidney disease and death with sodium‐glucose co‐transporter‐2 inhibitors compared with dipeptidyl peptidase‐4 inhibitors in type 2 diabetes regardless of prior cardiovascular or kidney disease: A retrospective cohort study in UK primary care
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 10, p. 2207, doi. 10.1111/dom.14437
- By:
- Publication type:
- Article
Insulin requirements are eternally dynamic.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 10, p. 2409, doi. 10.1111/dom.14460
- Publication type:
- Article
Glucokinase activation or inactivation: Which will lead to the treatment of type 2 diabetes?
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 10, p. 2199, doi. 10.1111/dom.14459
- By:
- Publication type:
- Article
Diabetes, Obesity and Metabolism.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 10, p. 2197, doi. 10.1111/dom.13784
- Publication type:
- Article